Abstract

The most fatal kind of cancer in women worldwide still is breast cancer. In order to improve care for women with breast cancer around the world, this study examines some of the epidemiological parallels and differences in breast cancer between white European women and black African women. African women experience breast cancer at a lower rate than their European counterparts. The majority of breast cancer patients in Europe are postmenopausal; however, premenopausal women in Africa have the highest incidence of the disease. The most typical kind of breast cancer in women in Africa and Europe is ductal carcinoma. However, compared to Europe, Africa has a higher prevalence of medullary and mucinous carcinomas. African women typically present late for treatment, which results in worse survival rates, whereas European women typically present at an early stage, especially with the advent of screening. African women should be the subject of additional molecular study to find out what genetic variables may increase their risk of breast cancer. To optimise care for women with breast cancer, the health care system in Africa should also be improved.

Breast cancer epidemiology in Europe and Africa:-

The Institute of Medical Education, Cardiff University School of Medicine, 5th Floor, Cochrane Building, Heath Park, CardiffCF14 4XW, UK2 is run by Ganiy Opeyemi Abdulrahman Jnr.1 and Ganiyu Adebisi Rahman. Ilorin 240001, Nigeria, University of Ilorin Teaching Hospital, Department of Surgery, and Division of General Surgery Please contact Ganiy Opeyemi Abdulrahman Jr. via email at ussheadie@hotmail.co.uk. Submitted on September 29, 2011, revised on February 19, 2012, and approved on March 11, 2012. P. Vineis is the academic editor. G. O. Abdul Rahman Jr. and G. A. Rahman, 2012, all rights reserved. The Creative Commons Attribution License, which this open access paper is given under, allows for free use, distribution, and reproduction in any format as long as the original work is properly attributed. The most fatal kind of cancer in women worldwide still is breast cancer. In order to improve care for women with breast cancer around the world, this study examines some of the epidemiological parallels and differences in breast cancer between white European women and black African women. African women experience breast cancer at a lower rate than their European counterparts. The majority of breast cancer patients in Europe are postmenopausal; however, premenopausal women in Africa have the highest incidence of the disease. The most frequent type of breast cancer in women in Africa and Europe is ductal carcinoma. Mucinous and medullary carcinomas, however, are more prevalent in Africa than in Europe. African women typically present late for treatment, which results in worse survival rates, whereas European women typically present at an early stage, especially with the advent of screening. African women should be the subject of greater molecular study to determine the hereditary elements that may increase their risk of breast cancer. To optimise care for women with breast cancer, the health care system in Africa should also be improved.

2. Probability:-

With over 16000 fatalities and almost 30000 new cases in 2008, breast cancer was the top cause of death for women in West Africa. With about 18000 new cases and 10000 deaths over the same year, Eastern Africa appears to have a substantially lower incidence. Five times more cases occur in Western Europe than in West Africa. Additionally, the number of breast cancer fatalities in 2008 was estimated to be around 40,000. Similar rates of occurrence—115,000 new cases and more than 47000 fatalities in 2008—can be found throughout Central and Eastern Europe. Additionally, it has been demonstrated that among American women of European ancestry, the incidence is significantly higher. Greater European ancestry has been linked to a higher risk of developing breast cancer, according to Fejerman and colleagues.

Conclusion:-

Review of the epidemiological parallels and divergences in breast cancer among females in Europe and Africa. African women should be the subject of additional molecular study to find out what genetic variables may increase their risk of breast cancer. In order to maximise care for women with breast cancer, the African health care system needs to be improved.